Answer
Because a risk to the breastfed child cannot be excluded, a decision must be made whether to discontinue breastfeeding or discontinue/abstain from Azarga treatment, taking into account the benefit of breastfeeding for the child and the benefit of treatment for the woman.
Sources for this answer
- Azarga 10mg/ml + 5mg/ml eye drops, suspensionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 13Document updated
Sources checked